Registration Opening Autumn 2021

ECMEC® credits


The WFH 2022 World Congress, Montreal, Canada, 08/05/2022-11/05/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

EACCME® credits

Breakdown of ECMEC®s per day:

09.05.2022 – 4.00

10.05.2022 – 4.00

11.05.2022 – 4.00

The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day. Cf. Chapter X of UEMS 2016.20.

Note for in-person participants – you will need to scan your badge before entering an ECMEC® credited session.
For virtual attendees – your attendance of the full hour of the session will be verified.

Please note that ECMEC® can only be obtained from viewing live sessions (viewing on-demand content does not qualify).

To request your ECMEC® certificate, please email: [email protected], please note that you must fill out the ECMEC® evaluation form for each session eligible for credits. The evaluation form can be found within the congress virtual platform by June 7, 2022.


Sessions eligible for ECMEC® credits:

  • Dental track: Impact of novel therapies on delivery of dental care
  • Dental track: Improving access to dental care
  • Dental track: Minimally invasive dental surgery for PwH
  • Free paper session: Inhibitors, Comorbidities, Prophylaxis
  • Free paper session: Oral health
  • Free paper session: Outcome research & Care delivery
  • Free Paper session: Young Researchers part 1
  • Free Paper session: Young Researchers part 2
  • Laboratory Sciences track: Advantages of external quality assessment-EQA programs
  • Laboratory Sciences track: Lab diagnosis of VWD
  • Laboratory Sciences track: New challenges for the coagulation laboratory
  • Medical session: Acquired bleeding disorders
  • Medical session: Big picture initiatives in bleeding disorders
  • Medical session: Comorbidities
  • Medical session: Gene therapy practical aspects of implementations
  • Medical session: Hemophilia gene therapy: Update on new country initiatives
  • Medical session: Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China
  • Medical session: Liver disease in bleeding disorders
  • Medical session: Low-dose prophylaxis and antifibrinolytics: options to consider with proven benefits for persons with hemophilia
  • Medical session: Non-factor therapy
  • Medical session: Diagnosis of rare bleeding disorders
  • Medical session: Managing invasive procedures in hemophilia patients with limited resources, extended half-life concentrates or non-replacement therapies in 2022
  • Medical session: von Willebrand disease and von Willebrand factor
  • Medical session: Health issues in women and girls affected by hemophilia
  • Musculoskeletal Free paper session: Musculoskeletal issues
  • Musculoskeletal track: Hot topic debates
  • Musculoskeletal track: Managing muscle bleeds
  • Musculoskeletal track: MSK complications – WFH guidelines
  • Musculoskeletal track: MSK management with and without technology
  • Musculoskeletal track: Revision surgery
  • Musculoskeletal track: Sports